Day One Biopharmaceuticals News

Day One Biopharmaceutical Analyst Ratings

BenzingaApr 25 17:28

Needham: Reiterates the Day One Biopharmaceutics (DAWN.US) rating and adjusted from buy to buy rating, target price of $33.00.

Zhitong FinanceApr 25 17:30

Needham Reiterates Buy on Day One Biopharmaceutical, Maintains $33 Price Target

BenzingaApr 25 17:29

Analysts Are Bullish on These Healthcare Stocks: Oculis Holding (OCS), Day One Biopharmaceuticals (DAWN)

TipRanksApr 24 18:21

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Biogen (BIIB) and Neurocrine (NBIX)

TipRanksApr 24 17:42

Needham: Maintaining the Day One Biopharmaceutics (DAWN.US) rating, adjusted from buy to buy rating, and adjusted the target price from $30.00 to $33.00.

Zhitong FinanceApr 24 17:30

Day One Biopharmaceutical Analyst Ratings

BenzingaApr 24 17:27

Needham Maintains Buy on Day One Biopharmaceutical, Raises Price Target to $33

BenzingaApr 24 17:28

Buy Rating on Day One Biopharmaceuticals Amid FDA Approval and Strong Market Prospects

TipRanksApr 24 03:05

Komo: Maintaining the Day One Biopharmaceutics (DAWN.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $32.00 to $36.00.

Zhitong FinanceApr 22 22:30

Day One Biopharmaceutical Analyst Ratings

BenzingaApr 22 22:29

Buy Rating Affirmed for Day One Biopharmaceuticals on Strong Tovorafenib Prospects and Market Impact

TipRanksApr 22 17:46

Analysts Are Bullish on These Healthcare Stocks: OptimizeRx (OPRX), Day One Biopharmaceuticals (DAWN)

TipRanksApr 16 21:00

Buy Rating on Day One Biopharmaceuticals Ahead of Tovorafenib PDUFA Date and Potential for Market Disruption

TipRanksApr 10 04:05

Day One Biopharmaceutical Analyst Ratings

BenzingaMar 26 19:58

Piper Sandler Maintains Overweight on Day One Biopharmaceutical, Maintains $40 Price Target

BenzingaMar 26 19:59

Analysts' Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), BioMarin Pharmaceutical (BMRN) and Argenx Se (ARGX)

TipRanksMar 26 19:10

Analysts Are Bullish on Top Healthcare Stocks: Day One Biopharmaceuticals (DAWN), Crinetics Pharmaceuticals (CRNX)

TipRanksFeb 29 21:10

Piper Sandler Cuts Price Target on Day One Biopharmaceuticals to $40 From $45, Maintains Overweight Rating

MT NewswiresFeb 29 00:11

Piper Sandler Maintains Overweight on Day One Biopharmaceutical, Lowers Price Target to $40

BenzingaFeb 28 23:45